Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone

J Clin Psychopharmacol. 2007 Oct;27(5):523-4. doi: 10.1097/JCP.0b013e31814f3178.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Dysmenorrhea / chemically induced
  • Female
  • Humans
  • Hyperprolactinemia / chemically induced*
  • Hyperprolactinemia / epidemiology
  • Male
  • Middle Aged
  • Prevalence
  • Prolactin / blood
  • Prolactin / drug effects*
  • Psychiatric Status Rating Scales
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*
  • Schizophrenia / drug therapy*
  • Sex Factors

Substances

  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Prolactin
  • Risperidone